Global Life Sciences Next-generation Customer Engagement Platforms Market Size Likely to Grow At a CAGR of 11.26% By 2034

October 10, 2025

Market Size and Growth

As per the Life Sciences Next-Generation Customer Engagement Platforms Market size analysis conducted by the BRI research team, the life sciences next-generation customer engagement platforms market is expected to record a CAGR of 11.26% from 2025 to 2034. In 2025, the market size was USD 3.64 Billion. By 2034, the valuation is anticipated to reach USD 9.46 Billion.

Overview

As per the industry experts at BRI, the global life sciences next-generation customer engagement platforms market will witness a noticeable CAGR between 2025 and 2034. This could be attributed to the growing inclination toward patient-centric care and digital transformation on this count. The key market growth factors are inclusive of demand for personalized content, omnichannel experiences, and real-time analytics for improving engagement with patients and healthcare providers.

Though challenges like data silos and legacy systems are there to stay, the leading players are partnering with providers of specialized CEPs for developing advanced solutions for better operational efficiency, engagement, and data-driven decision-making. AI is also playing a vital role in facilitating personalized, dynamic engagement strategies, thereby looking beyond conventional static approaches.

[ij_bar_charts reportid=”6721″]

Key Trends & Drivers

• Demand for Digital Transformation to Spell Growth: Rise in the integration of digital health solutions such as telemedicine and EHRs does drive the need for life sciences companies to engage in an effective manner through digital channels. Rising emphasis on customized care for patients does necessitate platforms capable of tailoring interactions and supporting patient outcomes. With hybrid models increasingly being adopted for engaging with the healthcare professionals (HCPs) and patients alike, demand for flexible, robust engagement tools is expected to increase.

• Demand for Personalized Experience to Catalyze Growth: The consumers are increasingly asking for personalized experience, thereby raising the expectations for immediate and tailored interactions within the life sciences vertical. The platforms are evolving to provide integrated, consistent experiences across numerous communication channels, thereby offering smooth interactions.

Report Scope

SWOT Analysis

• Strengths: The platforms foster more meaningful connections with the HCPs and patients beyond conventional sales-focused interactions. CEPs, by making provisions for personalized support, can notably improve health outcomes. Advanced analytics do provide real-time insights into preferences, customer behavior, and needs, thereby resulting in more effective strategies. Intelligent orchestration and automation within the CEPs are capable of streamlining processes and increasing productivity of marketing teams.

• Weaknesses: Many organizations are found struggling with the fragmented customer data and obsolete legacy systems that are likely to hinder innovation and integration. Tailoring as well as integrating the next-generation platforms for meeting the exclusive needs of life sciences companies could be a resource-intensive and complex process. The digital maturity gap could also be a barrier.

• Opportunities: Growing adoption of digital health solutions does create a wider requirement for sophisticated engagement tools. AI technologies do offer noticeable potential for automating content creation, personalizing experience at scale, and accelerating innovation. The Asia-Pacific is the fastest growing market. The opportunity exists in the extension of engagement beyond the initial prescribing for providing continuous support as well as education all through the treatment journey of the patient.

• Threats: The rapid pace of technological development needs continuous adaptation and investment from the life sciences companies. Collection and usage of patient data for engaging on personalized notes raises visible security and privacy challenges that require careful management.

[ij_bar_single_charts reportid=”6721″]

List of the prominent players in the Life Sciences Next-generation Customer Engagement Platforms Market:

• Aktana
• IQVIA (OCE)
• Veeva System
• Exeevo
• Pitcher
• Salesforce
• ACTO Technologies Inc.
• Alleg
• Bigtincan
• ODAIA Intelligence Inc.
• Qstream Inc.
• Seismic
• Tellius
• Viseven
• Vodori
• WhizAI
• ZS Associates
• Okra
• P360
• Quantified ai
• verbTEAMS SoloFire
• Others

The Life Sciences Next-generation Customer Engagement Platforms Market is segmented as follows:

By Component

• Software
• Services
• Implementation
• Integration
• Support

By Deployment Mode

• Cloud/SaaS
• Multi-tenant
• Subscription
• On-premise

By Functionality

• Core Engagement Layers
• End-to-end Content Management
• Engagement Channel Optimization
• Commercial Learning and Training
• Advanced Software Capabilities
• Cognitive Capabilities
• Functional Role Coverage
• Sales
• Marketing
• Medical Affairs
• Market Access
• Patient Services

By End-use

• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations (CROs)
• Medical Device Firms
• Research Institutes

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America